CSI-Glucagon

· Xeris Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CSI-Glucagon, covering 2019-12-10 to 2019-12-10. Get the full timeline:

Most recent: Clinical Trial Update: CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism [Phase 2]